Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1988 Jun;94(2):602-8.
doi: 10.1111/j.1476-5381.1988.tb11566.x.

Comparison of the binding of radiolabelled neurokinin A and eledoisin in rat cortex synaptic membranes

Affiliations
Comparative Study

Comparison of the binding of radiolabelled neurokinin A and eledoisin in rat cortex synaptic membranes

A C Foster et al. Br J Pharmacol. 1988 Jun.

Abstract

1. The binding of the 125I-Bolton Hunter (BH) conjugates of neurokinin A and eledoisin to synaptic plasma membranes prepared from rat cerebral cortex was investigated. 2. Saturation analyses indicated that both radioligands labelled a similar number of binding sites, but [125I]BH-eledoisin had a 7 fold higher affinity than [125I]BH-neurokinin A. 3. An identical pharmacological profile was apparent for both radioligands and tachykinin peptides inhibited the binding in the order: neurokinin B greater than BH-eledoisin greater than kassinin greater than L-363,851, eledoisin greater than substance P, neurokinin A greater than physalaemin greater than DiMeC7 greater than substance P methylester, indicating a profile consistent with the NK3-subtype of tachykinin receptors. 4. The binding of [125I]BH-neurokinin A and [125I]BH-eledoisin was equally sensitive to inhibition by the guanosine triphosphate (GTP) analogue, guanyly-5'-(beta-gamma-imido) diphosphate. 5. These results indicate that [125I]BH-neurokinin A and [125I]BH-eledoisin appear to label a common site in rat cerebral cortex synaptic plasma membranes with the characteristics of an NK3-receptor, and thus [125I]BH-neurokinin A is not a selective radioligand for the NK2-receptor.

PubMed Disclaimer

References

    1. Naunyn Schmiedebergs Arch Pharmacol. 1982 Mar;318(4):281-7 - PubMed
    1. Nature. 1980 Aug 21;286(5775):810-2 - PubMed
    1. Life Sci. 1984 Jul 9;35(2):179-84 - PubMed
    1. Eur J Pharmacol. 1984 Jul 13;102(2):361-4 - PubMed
    1. Mol Pharmacol. 1984 Sep;26(2):248-54 - PubMed

Publication types

LinkOut - more resources